Saito S

No ORCID on file · 30 papers in corpus
nonrandomized-trial 2003
Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover
Bone ·doi:10.1016/j.bone.2003.08.001

A novel cytokine termed osteoprotegerin (OPG) that is also called osteoclastogenesis-inhibitory factor, which inhibits osteoclast maturation and activity, was recently isolated. In order to determine the influence of estrogen deficiency on …

lab-animal 2002
HER2 is frequently over-expressed in ovarian clear cell adenocarcinoma: possible novel treatment modality using recombinant monoclonal antibody against HER2, trastuzumab
Japanese journal of cancer research : Gann ·doi:10.1111/j.1349-7006.2002.tb01231.x

Ovarian clear cell adenocarcinoma (CCA) is generally chemo-resistant. Recently the poor prognosis and resistance to chemotherapeutic agents of HER2/neu over-expressing tumors have become clear. Thus, we investigated the expression level of …

other 2001
Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma
The American journal of surgical pathology ·doi:10.1097/00000478-200105000-00016

The mechanism that regulates growth in ovarian clear cell adenocarcinoma (CCA) is not well understood. A high incidence of concurrent endometriosis with CCA may indicate that estrogen is a growth promotor in CCA. To determine estrogen as a …

case-report 1992
Pulmonary embolism after total hip replacement in a patient who had an ovarian cyst. A case report
The Journal of bone and joint surgery. American volume
other 1969
[Abnormal after-pains]
Sanfujinka no jissai. Practice of gynecology and obstetrics